KTM Ventures Innovation Fund
VC Fund
Sydney, Australia
KTM Ventures Innovation Fund is a VC fund in Sydney focused on Trading Platform and B2B. Running as a ESVCLP under the Australian Venture Capital Act, KTM Ventures Innovation Fund LP is a Tax-effective fund for high Investment returns behind pre-IPO and private expansion capital.Their differentiated position from traditional Venture Capital is the fund looks to help drive companies to the next level of growth and typically help IPOon the ASX. They work with founders and management on strategy execution, open their contact books for value adding board directors and other commercial investors and customers.KTM Ventures Innovation Fund LP provides direct access to high quality deal flow of unlisted and pre-IPO opportunities which do not fit the mandates of traditional investment firms.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries KTM Ventures Innovation Fund invests in
Stages KTM Ventures Innovation Fund invests in
Countries KTM Ventures Innovation Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Trading Platform 2 (29%)
- B2B 1 (14%)
- CRM 1 (14%)
- Banking 1 (14%)
- Bitcoin 1 (14%)
Stage
- Venture - Series Unknown 3 (43%)
- Seed 1 (14%)
- Series A 1 (14%)
- Series B 1 (14%)
- Series E 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Keith Kerridge
Partner
|
Partner | Total investments: 0 | Find email | |
Martin Rogers
Chief Investment Officer
|
Chief Investment Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| PrimeXConnect gives you a secure and private online space where you’re in control. Talk with your existing customers, manage inventory, negotiate pricing, and order in real-time, all in one place. So you’ll never drown in spreadsheets, faxes, emails, texts and sticky-notes again. We’re on a mission to free you from endless paperwork, tedious admin,manual data entry and accidental errors, that often costs thousands. All while keeping the best bits of old school sales, like great relationships, flexibility, and cross industry collaboration. | Series B / Oct 01, 2022 | ||
| Volt Bank is a bank that makes your life easier, not harder. | $11.6M / Series E / Jun 02, 2021 | ||
| Escavox provides independent and objective data on the performance of fresh food supply chains. | Series A / Jan 01, 2021 | ||
| Kaddy provides a wholesale beverage platform for craft beer, spirits, wine, and other beverages. The company creates an application to help breweries with their ordering processes. The company's platform allows on- and off-premise venues to easily access and place orders with a variety of different suppliers allowing bars and breweries tosimplify the ordering of alcohol. | $2.4M / Seed / Jun 03, 2020 | ||
| Zoom2u is a fast on demand courier service designed for business or personal use. It allows you to move your parcel from one location to the next and track where your parcel is in real time. We give you the ability to see the availability of our couriers and which courier is allocated to your booking. Zoom2u changes the way you send goods and howyou shop online, with e-commerce integration you are able to shop online and receive your goods within hours. | $4.2M / Venture - Series Unknown / Nov 11, 2019 | ||
| Actinogen Medical is biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive.Actinogen Medical is an ASX-listed biotechnology company developing innovative treatments for Alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2diabetes.Our management team and scientific advisory board includes world-renowned Alzheimer’s disease and dementia researchers, and industry specialists in drug design and clinical trial management.Actinogen Medical’s drug candidate Xanamem has been specifically designed to block the production of cortisol in the brain. Drugs that reduce cortisol in the brain offer a promising new approach to slowing, or even preventing, the cognitive decline associated with Alzheimer’s disease.Actinogen Medical is currently conducting XanADu, an international multi-site Phase II efficacy and safety trial of Xanamem in patients with mild Alzheimer’s disease. Recruitment and treatment of patients started in 2017, with results expected in early 2019. | Venture - Series Unknown / Jan 01, 2017 | ||
| Independent Reserve is a Bitcoin and Digital Currency exchange where investors, traders and everyday people come to buy and sell Bitcoin, Ether and Bitcoin Cash. | Venture - Series Unknown / Jan 01, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does KTM Ventures Innovation Fund invest in?
KTM Ventures Innovation Fund invests primarily in Trading Platform, B2B and CRM startups, most often at Venture - Series Unknown and Seed stage. Most of the 7 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact KTM Ventures Innovation Fund?
Public channels for KTM Ventures Innovation Fund include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at KTM Ventures Innovation Fund?
The team at KTM Ventures Innovation Fund includes Keith Kerridge (Partner) and Martin Rogers (Chief Investment Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
